BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, November 26, 2024
See today's BioWorld MedTech
Home
» SGR, cost of PPACA's reforms, omitted in reimbursement talk
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
SGR, cost of PPACA's reforms, omitted in reimbursement talk
Oct. 20, 2010
By
Mark McCarty
No Comments
WASHINGTON – If predictability is the Holy Grail of industry, the search is presumed to be ongoing thanks to, among other things, the uncertainties engendered by the Patient Protection and Affordable Care Act of 2010 (PPACA). (Medical Device Daily)
BioWorld MedTech